Patrick Burnett Sells $30K of Arcutis Biotherapeutics Inc (ARQT) — SEC Form 4, Nov 04, 2026

Open-Market Net Sale · SEC Form 4

−$30,047

Equity position changed by -0.8%

Reporting Owner

Patrick Burnett

EVP

TXN 2026-11-02 · FILED 2026-11-04

Equity Position 117K sh 117,592 → 116,649

Equity Change -0.8% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Arcutis Biotherapeutics Inc

ARQT CIK 0001787306

Reporting Owner

Name	Relationship
Patrick Burnett CIK 0001741987	EVP

Patrick Burnett at Arcutis Biotherapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $1,893,025

More from this insider at Arcutis Biotherapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2026-11-02	S - Sale	943 D	$31.86	-$30,047	116,649	Direct

Footnotes (2)

F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. Show more
F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Arcutis Biotherapeutics Inc

GET /v1/forms/4/0001628280-26-070383 API docs